Surgery Partners reports Q4 adjusted EPS 44c, consensus 38c

Reports Q4 revenue $864.4M, consensus $828.09M. Eric Evans, Chief Executive Officer, stated, “We are pleased to report another year of mid-teens growth, while continuing to expand margin. Our 2024 results are a continuation of the Company’s consistent and predictable organic growth, with same-facility revenue growth of 8.0%. During 2024 we deployed nearly $400 million on accretive acquisitions and opened eight de novo facilities to further expand our portfolio of high quality, short-stay surgical facilities offering exceptional value to our patients, health plans, and the communities we serve. I would like to thank my colleagues as well as our physician partners for once again delivering excellent results and for positioning Surgery Partners (SGRY) for sustained success in 2025 and beyond.”